Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests

J Rheumatol. 2021 Dec;48(12):1771-1773. doi: 10.3899/jrheum.201510. Epub 2021 May 15.

Authors

Johannes W G Jacobs¹, Maxime M A Verhoeven¹, Paco M J Welsing¹

Affiliation

¹ J.W. Jacobs MD, PhD, Associate Professor, M.M. Verhoeven, MSc, P.M. Welsing, PhD, University Medical Center Utrecht, Utrecht, the Netherlands.

PMID: 33993116
DOI: 10.3899/jrheum.201510

No abstract available

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Cost-Benefit Analysis
Humans

Substances

Antirheumatic Agents